ਕੈਨੇਡਾ ਦੁਆਰਾ ਪ੍ਰਾਪਤ ਕੀਤੀ ਗਈ ਪਹਿਲੀ ਨਵੀਂ ਕੋਵਿਡ-19 ਓਰਲ ਟ੍ਰੀਟਮੈਂਟਸ

ਇੱਕ ਹੋਲਡ ਫ੍ਰੀਰੀਲੀਜ਼ 2 | eTurboNews | eTN

Today, the Honourable Filomena Tassi, Minister of Public Services and Procurement, announced that the Government of Canada has received an initial shipment of 30,400 treatment courses of Pfizer’s COVID-19 oral antiviral treatment, PAXLOVIDTM, with 120,000 more expected to be delivered between now and the end of March. The treatment received Health Canada regulatory authorization earlier today.

The Government of Canada is committed to protecting the health and safety of everyone in Canada from COVID 19. This includes securing safe and effective treatments as they become available.

Vaccination and public health measures remain the best way to protect the public against infection and severe disease. However, access to effective, easy-to-use treatments, such as the one produced by Pfizer, could be critical to reducing the severity of COVID-19 in people who become infected.

Distribution to provinces and territories will begin imminently. The Government of Canada is working closely with the provinces and territories to coordinate distribution of treatment courses across the country. The Public Health Agency of Canada met with provincial and territorial officials to discuss deployment based on a per capita basis with adjustments due to shipping requirements from Pfizer.

Canada has secured 1 million courses of the treatment. Delivery schedules are being finalized, with the intent of bringing additional treatment courses to Canada as quickly as possible.

ਲੇਖਕ ਬਾਰੇ

ਲਿੰਡਾ ਹੋਨਹੋਲਜ਼ ਦਾ ਅਵਤਾਰ

ਲਿੰਡਾ ਹੋਨਹੋਲਜ਼

ਲਈ ਮੁੱਖ ਸੰਪਾਦਕ eTurboNews eTN HQ ਵਿੱਚ ਅਧਾਰਤ।

ਗਾਹਕ
ਇਸ ਬਾਰੇ ਸੂਚਿਤ ਕਰੋ
ਮਹਿਮਾਨ
0 Comments
ਇਨਲਾਈਨ ਫੀਡਬੈਕ
ਸਾਰੀਆਂ ਟਿੱਪਣੀਆਂ ਵੇਖੋ
0
ਟਿੱਪਣੀ ਕਰੋ ਜੀ, ਆਪਣੇ ਵਿਚਾਰ ਪਸੰਦ ਕਰਨਗੇ.x
ਇਸ ਨਾਲ ਸਾਂਝਾ ਕਰੋ...